DSpace@İnönü

Yazar "Odabas, H" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Yazar "Odabas, H" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Sırala: Sıra: Sonuçlar:

  • Treatment preferences in stage IA and IB testicular seminoma: 
    Bilici, A; Ozturk, T; Turkmen, E; Odabas, H; Cihan, S; Selcukbiricik, F; Erdogan, B; Urakci, Z; Kandemir, N; Bayoglu, IV; Demirci, U; Duran, AO; Sendur, MAN; Yavuzer, D; Harputluoglu, H; Kavgaci, H; Gumus, M (2015)
    Approximately 75 % of patients with testicular seminoma present with stage I disease, and the probability of long-term survival approaches 100 %. However, the standard adjuvant treatment for stage I seminoma patients remains ...
  • Treatment preferences in stage IA and IB testicular seminoma: 
    Bilici, A; Ozturk, T; Turkmen, E; Odabas, H; Cihan, S; Selcukbiricik, F; Erdogan, B; Urakci, Z; Kandemir, N; Bayoglu, IV; Demirci, U; Duran, AO; Sendur, MAN; Yavuzer, D; Harputluoglu, H; Kavgaci, H; Gumus, M (2015)
    Approximately 75 % of patients with testicular seminoma present with stage I disease, and the probability of long-term survival approaches 100 %. However, the standard adjuvant treatment for stage I seminoma patients remains ...
  • Is second-line systemic chemotherapy beneficial in patients with 
    Odabas, H; Ulas, A; Aydin, K; Inanc, M; Aksoy, A; Yazilitas, D; Turkeli, M; Yuksel, S; Inal, A; Ekinci, AS; Sevinc, A; Demirci, NS; Uysal, M; Alkis, N; Dane, F; Aliustaoglu, M; Gumus, M (2015)
    Patients with advanced non-small cell lung cancer (NSCLC) generally require second-line treatment although their prognosis is poor. In this multicenter study, we aimed to detect the characteristics related to patients and ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...